成都哪家医院治疗糖足(成都哪里的血糖足医院好) (今日更新中)

The mad scramble between Thanksgiving and Christmas just got six days shorter.Black Friday once again kicks off the start of the holiday shopping season. But with six fewer days than last year, it will be the shortest season since 2013 because Thanksgiving fell on the fourth Thursday in November — the latest possible date it could be. That means customers will have less time to shop and retailers will have less time to woo them.Adobe Analytics predicts a loss of billion in online revenue from a shortened season. Still, it expects online sales will reach 3.7 billion, up 14.1% from last year’s holiday seasonThe National Retail Federation, the nation’s largest retail trade group, baked the shorter season into its forecast, but it says the real drivers will be the job market. It forecasts that holiday sales will rise between 3.8% and 4.2%, an increase from the disappointing 2.1% growth seen in the November and December 2018 period that came well short of the group’s prediction.Last year’s holiday sales were hurt by turmoil over the White House trade policy with China and a delay in data collection by nearly a month because of a government shutdown. This year’s holiday forecast is above the average holiday sales growth of 3.7% over the previous five years.NRF expects online and other non-store sales, which are included in the total, to increase between 11% and 14%, for the holiday period.Black Friday is expected to once again be the largest shopping day of the season, followed by the last Saturday before Christmas, according to MasterCard SpendingPulse, which tracks spending across all types of payments including cash and check. Thanksgiving Day isn’t even on the top 10 holiday shopping days, according to MasterCard.The 2019 holiday season will be a good measure of the U.S. economy’s health. Many retail CEOs describe their customers has financially healthy, citing moderate wage growth and an unemployment rate hovering near a 50-year low.“The overall picture is positive,” said Craig Johnson, president of Customer Growth Partners, a retail consultancy. “People are spending out of positive cash flow as opposed to borrowing.”Economic growth has moderated since earlier this year, with growth at just 1.9% in the July-September quarter, down from 3.1% in the first three months of the year. Analysts blame at least part of that on the U.S.-China trade war, which has forced many companies to delay plans to invest and expand.That’s left consumers as the main drivers. So far, Americans have kept up their spending, allaying fears of a recession.With more holiday deals happening earlier to compensate for the late start, many have already started to shop. More than half of consumers have already started their holiday shopping and nearly a quarter of purchases have already been made, according to the annual survey released by the NRF and Prosper Insights & Analytics. The survey of 7,917 adult consumers was conducted Oct. 31 through Nov. 6.“This is further evidence that the holiday season has grown far beyond the period between Thanksgiving and Christmas,” said Matthew Shay, president and CEO of NRF, in a statement. 3173

The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.Public health officials say it will take a year to 18 months to fully validate any potential vaccine. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people’s health a month or two at a time while longer-lasting protection is developed.Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.Even if initial safety tests go well, “you’re talking about a year to a year and a half” before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH’s National Institute of Allergy and Infectious Diseases.That still would be a record-setting pace. But manufacturers know the wait — required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm — is hard for a frightened public.President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is “moving along very quickly” and he hopes to see a vaccine “relatively soon.”Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia. The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover.___The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 3597

The Department of Health and Human Services experienced a cyber attack on Sunday evening, one that was designed to slow down computer systems as the agency responds to the COVID-19, pandemic, 204

The Dow finished down more than 600 points Monday after China said it will raise tariffs in retaliation to last week's tariff increase by the United States.China hiked 180

Tens of thousands of people were without power in Manhattan on Saturday evening, ConEdison said.There were 42,000 customers without power in New York, most of them in Midtown Manhattan and the Upper West Side, the utility company said.Mayor Bill de Blasio, who was campaigning for president in Iowa, said it appears the outage was the result of a mechanical problem in the electrical grid."This appears to be something that just went wrong in the way that they transmit power from one part of the city to another," he told CNN. "It sounds like it is addressable in a reasonable amount of time."The city's fire department was responding to numerous transformer fires, the first of which occurred in Manhattan on West 64th Street and West End Avenue, officials said.Several Broadway and off-Broadway shows said they were canceling performances, according to tweets aggregated by 889

来源：资阳报